The vast majority of glioblastoma (GBM) cases are not hereditary. Roughly 5% of all gliomas, the broader category that includes GBM, are considered familial, meaning multiple members of the same family develop the disease. Even within that 5%, most cases aren’t driven by a single inherited gene the way some breast cancers are linked to BRCA mutations. True hereditary glioblastoma, caused by a clear genetic syndrome passed from parent to child, accounts for a statistically tiny fraction of all cases.
So if you or someone you love has been diagnosed with GBM and you’re wondering whether your family is at risk, the short answer is that the odds are low. But “low” isn’t “zero,” and the details matter.
What “Familial” Actually Means for Glioblastoma
Researchers draw a distinction between hereditary and familial cancers. Hereditary means a specific gene mutation is passed down in a predictable pattern and directly causes the cancer. Familial is a broader term: it means the cancer shows up more than once in a family, but the reason might be shared genetics, shared environment, or simply chance. Most of the 5% of familial glioma cases fall into this murkier category. When scientists compared familial gliomas to sporadic (random) ones, they found no significant differences in the age patients were diagnosed or in how the tumors behaved at the molecular level. Familial gliomas don’t appear to be more aggressive, and they don’t progress to fatal GBM any faster than sporadic ones.
That’s a meaningful contrast with other familial cancers. Hereditary breast cancer linked to BRCA mutations, for example, tends to strike at younger ages and carry worse outcomes. Familial glioma doesn’t follow that pattern, which suggests that for most families, the clustering of cases may not reflect a single powerful inherited mutation at all.
Genetic Syndromes That Do Raise Risk
A small number of rare inherited conditions genuinely increase the likelihood of developing glioblastoma. The most well-established include:
- Li-Fraumeni syndrome: Caused by inherited mutations in the TP53 gene, a critical tumor suppressor. People with this syndrome face elevated risk for many cancers, including breast, soft-tissue sarcoma, and brain tumors like GBM.
- Lynch syndrome: Caused by mutations in mismatch repair genes (MSH2, MLH1, MSH6, PMS2) that normally fix errors when DNA copies itself. Lynch syndrome is best known for increasing colorectal and endometrial cancer risk, but it also raises the risk of glioblastoma.
- Turcot syndrome (type 1): Closely related to Lynch syndrome, this condition involves mutations in the same DNA repair genes and is associated with brain tumors in children and young adults.
- Neurofibromatosis: Caused by mutations in the NF1 gene, which helps regulate cell growth signaling. This syndrome primarily causes benign nerve tumors but also increases glioma risk.
Other rare conditions linked to glioma include tuberous sclerosis, melanoma-neural system tumor syndrome, and Ollier disease. All of these syndromes are uncommon on their own, and collectively they explain only a sliver of glioblastoma diagnoses.
Genes Involved Beyond Known Syndromes
Researchers have been searching for inherited gene variants that raise GBM risk outside of these well-known syndromes. A study that screened over 200 glioma patients from families with suspected genetic predisposition found that mutations in BRCA2 (more commonly associated with breast cancer) play a role in some adult gliomas. The same study confirmed that variants in genes involved in DNA repair, including ATM, PMS2, and POLE, are associated with glioma risk.
Large-scale genetic studies scanning the entire genome have also identified specific locations in DNA linked to GBM susceptibility. One such region, on chromosome 12, appears to be specific to glioblastoma rather than other glioma types. These variants each contribute only a small increase in risk on their own. They’re common in the general population and don’t cause disease by themselves, but they may nudge risk slightly higher when combined with other factors.
The Role of Environment
If genetics explains only a small share of glioblastoma cases, what causes the rest? The honest answer is that researchers still don’t know for most patients. Moderate-to-high-dose ionizing radiation is the only environmental risk factor that’s been firmly established for brain tumors. This link comes from studies of atomic bomb survivors and children who received radiation therapy for other conditions. Everyday exposures like cell phones, pesticides, and power lines have been studied extensively without producing consistent evidence of a connection.
For the average GBM patient, the tumor appears to arise from random genetic mutations that accumulate in brain cells over a lifetime, not from anything inherited or anything that could have been avoided.
When Genetic Counseling Makes Sense
Because so few brain tumors are hereditary, genetic testing isn’t automatically recommended for every GBM patient or their relatives. A genetic counselor can evaluate your specific situation by looking at your personal and family medical history. Testing is most likely to be useful when there’s a pattern: multiple family members diagnosed with cancer (especially at younger ages), cancers that match a known syndrome like Li-Fraumeni or Lynch, or a family member diagnosed with glioma before age 50.
Predictive genetic testing typically uses a blood or saliva sample to look for inherited variants in genes associated with cancer predisposition. If a variant is found, it can help guide screening for other cancers that the same syndrome might cause, and it gives other family members the option of learning their own status. If no variant is found, that’s reassuring, though it doesn’t reduce risk to zero since current testing can’t detect every possible genetic contributor.
For most people with a single family member diagnosed with GBM and no broader pattern of cancer in the family, the inherited risk to other relatives remains very low.